Can't Stop Us Now: CRO Growth Amid Uncertainty

By Laura McWhinney, Market Research Manager, Industry Standard Research (ISR)

Despite the global pandemic and economic uncertainty, the CRO market has been experiencing consistent growth, which is expected to continue. Factors such as the increasing number of clinical trials, increased outsourcing of research and development, and the demand for specialized services drive this market. Additionally, the rise of biologics and the need for advanced treatments for chronic disorders have further contributed to the growth of the CRO market.

As these needs and revenue for pharmaceutical companies continue to climb, the life sciences industry has witnessed increased investment in research and development (R&D) and an uptick in the ongoing growth of the CRO market overall. According to Industry Standard Research (ISR), projections for 2023 indicate expenditures and distribution percentages across various service categories within the CRO industry.

Read the article to learn more about where the market is headed.